Literature DB >> 22192143

Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over-expressing MMP9.

Apostolia Fragkouli1, Costas Papatheodoropoulos, Spiros Georgopoulos, Antonios Stamatakis, Fotini Stylianopoulou, Effie C Tsilibary, Athina K Tzinia.   

Abstract

Evidence accumulating during the past few years points to a significant role of matrix metalloproteinase 9 (MMP9) enzymatic activity in synaptic plasticity and cognitive processes. We have previously demonstrated that MMP9 is involved in receptor-mediated α-secretase-like cleavage of APP in vitro, resulting in increased secretion of sAPPα, the soluble N-terminal product of the non-amyloidogenic pathway known to be involved in neuronal plasticity and memory formation. To study the in vivo role of MMP9, we have generated transgenic mice over-expressing MMP9 in the brain. Herein, we demonstrate that MMP9 transgenic animals display enhanced performance in the non-spatial novel object recognition and the spatial water-maze task and that their enhanced performance was accompanied by increased dendritic spine density in the hippocampus and cortex following behavioural testing. Consistent with the above observations, the electrophysiological analysis revealed prolonged maintenance of long-term synaptic potentiation in hippocampal slices from MMP9 transgenic mice. Moreover, elevated sAPPα levels in the hippocampus and cortex of MPP9 transgenic animals were also observed. Overall, our results extend previous findings on the physiological role of MMP9 in neuronal plasticity and furthermore reveal that, APP may be one of the physiological proteolytic targets of MMP9 in vivo.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22192143     DOI: 10.1111/j.1471-4159.2011.07637.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

Review 1.  The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.

Authors:  Ivan L Salazar; Margarida V Caldeira; Michele Curcio; Carlos B Duarte
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

Review 2.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 3.  Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.

Authors:  Katarzyna Lepeta; Leszek Kaczmarek
Journal:  Schizophr Bull       Date:  2015-04-02       Impact factor: 9.306

4.  Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP).

Authors:  Myrta Kostomoiri; Apostolia Fragkouli; Marina Sagnou; Leandros A Skaltsounis; Maria Pelecanou; Effie C Tsilibary; Athina K Tzinia
Journal:  Cell Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.046

Review 5.  Implication of matrix metalloproteinases in regulating neuronal disorder.

Authors:  Abhishek Mukherjee; Snehasikta Swarnakar
Journal:  Mol Biol Rep       Date:  2015-01       Impact factor: 2.316

Review 6.  Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

Authors:  George W Huntley
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

7.  Venlafaxine Stimulates an MMP-9-Dependent Increase in Excitatory/Inhibitory Balance in a Stress Model of Depression.

Authors:  Seham Alaiyed; Mondona McCann; Gouri Mahajan; Grazyna Rajkowska; Craig A Stockmeier; Kenneth J Kellar; Jian Young Wu; Katherine Conant
Journal:  J Neurosci       Date:  2020-04-08       Impact factor: 6.167

8.  The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study.

Authors:  Johanna Seitz-Holland; Magdalena Seethaler; Nikos Makris; Jarrett Rushmore; Kang-Ik K Cho; Elizabeth Rizzoni; Mark Vangel; Olcay Senay Sahin; Carina Heller; Ofer Pasternak; Filip Szczepankiewicz; Carl-Fredrik Westin; Jan Lošák; Libor Ustohal; Josef Tomandl; Lubomír Vojtíšek; Petr Kudlička; Martin Jáni; T Wilson Woo; Tomáš Kašpárek; Zora Kikinis; Marek Kubicki
Journal:  Neuropsychopharmacology       Date:  2021-04-08       Impact factor: 7.853

9.  MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons.

Authors:  Mark Niedringhaus; Xin Chen; Rhonda Dzakpasu; Katherine Conant
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.

Authors:  Baptiste Lacoste; Xin-Kang Tong; Karim Lahjouji; Réjean Couture; Edith Hamel
Journal:  J Neuroinflammation       Date:  2013-05-04       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.